Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Vilin Bio Med Ltd

Pharmaceuticals | Small Cap

Vilin Bio Med Ltd Health Insights
Health Score : 4.49Health Score : 4.49

Vilin Bio Med Ltd demonstrates a mixed financial performance. The company shows strong growth in revenue, assets, and net income, indicating expansion and market potential. Its debt levels are well-managed. However, profitability metrics such as ROCE, ROE, and ROA are low, suggesting challenges in generating returns from its capital and assets. The company's efficiency ratios also indicate issues with inventory and receivables management. The current level of earnings, book value, and dividend distribution are low. While the company is growing, it needs to improve its profitability and operational efficiency to achieve a more robust financial standing. The coverage ratios suggest challenges in meeting interest obligations. The company's negative cash flow from operations requires careful monitoring to ensure long-term sustainability. Recent improvements in cash ratios provide a positive outlook, but consistent profitability and efficient operations are crucial for future success.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Vilin Bio Med Ltd Health Insights
Health Score : 4.49Health Score : 4.49

Vilin Bio Med Ltd demonstrates a mixed financial performance. The company shows strong growth in revenue, assets, and net income, indicating expansion and market potential. Its debt levels are well-managed. However, profitability metrics such as ROCE, ROE, and ROA are low, suggesting challenges in generating returns from its capital and assets. The company's efficiency ratios also indicate issues with inventory and receivables management. The current level of earnings, book value, and dividend distribution are low. While the company is growing, it needs to improve its profitability and operational efficiency to achieve a more robust financial standing. The coverage ratios suggest challenges in meeting interest obligations. The company's negative cash flow from operations requires careful monitoring to ensure long-term sustainability. Recent improvements in cash ratios provide a positive outlook, but consistent profitability and efficient operations are crucial for future success.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

186.94

Neutral

Industry Median

19.41

Neutral
Neutral

Small Cap Median

18.08

Neutral

P/E RATIO

210.31

P/B RATIO

2.03

Neutral

Industry Median

1.98

Neutral
Neutral

Small Cap Median

2.03

Neutral

P/S RATIO

N/A

Neutral

Industry Median

2.06

Neutral
Neutral

Small Cap Median

1.64

Neutral

Others

Overvalued

PEG RATIO

31.96

Overvalued
Overvalued

EV/EBITDA RATIO

37.39

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹33.65 as on Feb 20, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 7.70

The company exhibits strong growth in revenue, assets, and net income, demonstrating positive expansion. However, the negative EPS growth indicates underlying profitability issues. While the company is growing, it needs to ensure that this growth translates into increased earnings and shareholder value. Focusing on sustainable and profitable growth is crucial for maintaining long-term financial health and attracting investors.

ExcellentRevenue Growth RateExcellent
GoodOperating Profit Growth RateGood
PoorEarnings Per Share (EPS) GrowthPoor
ExcellentAsset Growth RateExcellent
ExcellentNet Income Growth RateExcellent
Growth RatiosMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue Growth RateN/AN/AN/AN/AN/A
Operating Profit Growth Rate-5.49-10.47235.06-67.83-4.82
Earnings Per Share (EPS) Growth-25-751300-91.2745.45
Asset Growth RateN/A-2.3830.3883.26-14.41
Net Income Growth RateN/AN/AN/AN/AN/A
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 4.00

The financial ratios present a mixed view. Capital expenditure is effectively managed, however, there are low earnings and book value per share. While the company manages its capital expenditures well, the low earnings and book value per share need to be addressed to enhance overall financial strength and shareholder value.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
WeakCash Earnings Per Share (Cash EPS)Weak
PoorBook Value Per SharePoor
PoorDividend Per Share (DPS)Poor
ExcellentCapital Expenditures (CapEx)Excellent
Financial RatiosMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Adjusted Earnings Per Share (Adjusted EPS)N/AN/AN/AN/AN/A
Cash Earnings Per Share (Cash EPS)N/AN/AN/AN/AN/A
Book Value Per Share22.322.4210.7916.3116.47
Dividend Per Share (DPS)00000
Capital Expenditures (CapEx)00000
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 2.30

The company's profitability ratios indicate significant challenges in generating profits from its revenue, capital, and assets. The low gross profit margin, ROCE, ROE, ROA, operating margin, and net margin suggest inefficiencies in cost management and asset utilization. Improving these ratios is crucial for enhancing the company's overall financial health and attracting investors.

WeakGross Profit MarginWeak
PoorReturn on Capital Employed (ROCE)Poor
PoorReturn on Equity (ROE)Poor
PoorReturn on Assets (ROA)Poor
PoorOperating MarginPoor
PoorNet MarginPoor
Profitability RatiosMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Gross Profit MarginN/AN/AN/AN/AN/A
Return on Capital Employed (ROCE)N/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Operating MarginN/AN/AN/AN/AN/A
Net MarginN/AN/AN/AN/AN/A
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 2.00

The company's efficiency ratios indicate significant challenges in managing its assets. The low inventory and receivables turnover ratios, coupled with high receivable days and days sales in inventory, suggest inefficiencies in working capital management. This can lead to tied-up capital and increased operational costs. Improving these ratios is essential to enhancing the company's overall financial performance and optimizing resource utilization.

PoorInventory Turnover RatioPoor
PoorReceivables Turnover RatioPoor
PoorDays Sales in Inventory RatioPoor
PoorReceivable DaysPoor
Efficiency RatiosMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Fixed Asset Turnover RatioN/AN/AN/AN/AN/A
Inventory Turnover RatioN/AN/AN/AN/AN/A
Receivables Turnover RatioN/AN/AN/AN/AN/A
Days Sales in Inventory RatioN/AN/AN/AN/AN/A
Receivable DaysN/AN/AN/AN/AN/A
Capital Turnover Ratio00000
01.

Inventory Turnover Ratio

02.

Receivables Turnover Ratio

03.

Days Sales in Inventory Ratio

04.

Receivable Days

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 2.00

The company's coverage ratios reveal challenges in meeting its interest obligations. The low interest coverage ratio suggests vulnerability in covering interest expenses from its earnings. Enhancing operational performance and reducing debt could improve its ability to cover interest expenses effectively.

PoorInterest Coverage RatioPoor
AverageEquity Dividend Coverage RatioAverage
Coverage RatiosMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Interest Coverage Ratio1.491.361.083.741.291.36
Equity Dividend Coverage RatioN/AN/AN/AN/AN/AN/A
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company maintains a strong solvency position, reflected in its low debt ratios. This indicates a conservative capital structure, which reduces financial risk. However, the interest coverage ratio suggests some vulnerability in meeting interest obligations from its earnings. While the low debt levels provide stability, the company needs to enhance its operational performance to improve its ability to cover interest expenses effectively.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
AverageInterest Coverage RatioAverage
Solvency RatiosMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debt Ratio00000
Debt to Equity Ratio00000
Equity Ratio11111
Debt To Asset Ratio00000
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Interest Coverage Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 0.00

The company's liquidity position cannot be determined based on the provided data because the liquidity score is zero. This suggests that there is missing or insufficient information to assess the company's ability to meet its short-term obligations. Without adequate data on current, quick, and cash ratios, it is impossible to provide a meaningful analysis of the company's liquidity strengths and weaknesses.

AverageCurrent RatioAverage
AverageQuick RatioAverage
AverageCash RatioAverage
Liquidity RatiosMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Current RatioN/AN/AN/AN/AN/A
Quick RatioN/AN/AN/AN/AN/A
Cash RatioN/AN/AN/AN/AN/A
Operating Cash Flow RatioN/AN/AN/AN/AN/A
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

Peer Comparison With 1 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Vilin Bio Med Ltd4.49210.31Neutral0.790.160.22
Management Assessment Summary
OrangeBalanced Management

Vilin Bio Med Ltd's management effectiveness is assessed as mixed. While sales increased in fiscal year 2024, TTM sales declined. Profitability shows volatility, and capital efficiency is weak. Financial health is strained due to increasing borrowings. Promoter holding remains substantial but has decreased recently.

Category Metric Value Assessment
PROS Sales Growth (2024) 28.35% Significant increase in sales growth.
CONS TTM Sales Growth -20% Concerning decline in recent sales trend.
ROCE (2024) 4.51% Low return on capital employed.
Promoter Holding Change (Sep 2023 to Sep 2024) Decrease of 0.43% Slight decrease in promoter confidence.
AverageFinancial Performance & GrowthAverage
WeakCapital Efficiency & ReturnsWeak
WeakFinancial Health & PrudenceWeak
AverageShareholding & Ownership StructureAverage
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

Vilin Bio Med Ltd faces a moderate level of risk. Concerns stem from segment performance volatility, reflected in fluctuating sales and profit margins. Increasing debt levels and negative cash flows from operating activities further contribute to the risk profile. While promoter holding remains significant, its recent decrease adds to the uncertainty.

AverageSegment performance volatilityAverage
01.

Segment performance volatility

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 2 Hours Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 4 Hours Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Day Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Week Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Month Timeframe